Eckert & Ziegler BEBIG is the exclusive manufacturer of Ru-106 (Ruthenium-106) Ophthalmic Plaques, used to treat uveal melanoma and retinoblastoma.
The plaques consist of a thin film of Ru-106, a beta emitter, encapsulated within pure silver sheets with a total thickness of only 1mm. Due to its half-life of 374 days, the Ru-106 Ophthalmic Plaques can be used a number of times within one year.
SagiNova® HDR afterloader was designed to address today´s needs for HDR brachytheraphy applications regarding safetly, seamless workflows, and cost efficiency. With the help of applicators and catheters, a very small radiation source is driven from a shielded safe – located inside the afterloader – directly into or next to the tumour.
We provide permanent, radioactive implants –seeds- which are used in LDR brachytherapy, mainly in the treatment of localized prostate cancer where they destroy the cancer cells.
Available is also treatment planning software (such as PSID), ultrasound scanners and a complete range of accessories, as well as professional training.